Kobe University Capital
Kobekuc.vc
Overview
Kobe University Capital is a venture capital firm that invests in university-launched ventures and regional startups, primarily focusing on research outcomes from Kobe University and the Kansai area. It was established as a subsidiary of Kobe University Innovation. The firm manages the KUC Fund 1, which was launched with 2 billion JPY from private capital.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Luxna Biotech Co., Ltd. | Aug 2025 | Series C Extension | Co-investor |
| Link Therapeutics Inc. | Jul 2025 | Series B | Co-investor |
| Link Therapeutics, Inc. | Jul 2025 | Series B | Co-investor |
| TelaAxon, Co., Ltd. | Jan 2025 | Series A | Lead |
| Optieum Biotechnologies | Jan 2025 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
